Table 2.
SUV and TATV results of primary tumors
| Patient | SUVmax [g/mL] | SUVmean [g/mL] | SUV42%/SUVbackground [1] | Tracer avid tumor volume [cm3] | ||||
|---|---|---|---|---|---|---|---|---|
| FDG | RGD | FDG | RGD | FDG | RGD | FDG | RGD | |
| 1 | 11.6 | 3.5 | 9.1 | 2.4 | 9.3 | 3.3 | 3.7 | 21 |
| 2 | 14.3 | 2.5 | 12.5 | 2.9 | 15.3 | 5 | 2.3 | 12.9 |
| 3 | 20.6 | 5.2 | 9 | 2.1 | 16.6 | 3.8 | 10.5 | 34.7 |
| 4 | 10.6 | 3.2 | 6.7 | 1.9 | 10.8 | 2.7 | 2.4 | 8.1 |
| 5 | 7.6 | 3.1 | 5.5 | 0.4 | 10.8 | 2.8 | 1.2 | 3.5 |
| 9.7 | 4.8 | 8.7 | 2.7 | 8.7 | 4.4 | 4.2 | 12.3 | |
| 6 | 16.6 | 4.4 | 10.4 | 2.8 | 9.1 | 4.8 | 8.5 | 17 |
| 7 | 8.6 | 4.8 | 5 | 2.7 | 9.5 | 5.3 | 5 | 6.4 |
| 8 | 8.5 | 4.5 | 5.3 | 2.3 | 7.7 | 4.8 | 28.6 | 38 |
| 9 | 8.7 | 2.1 | 4.9 | 0.9 | 9.6 | 2 | 6 | 8.1 |
| 10 | 28.3 | 2.3 | 14 | 1.2 | 31.4 | 2.5 | 10 | 16 |
| Mean | 14 | 3.9 | 8.2 | 2.0 | 12.7 | 3.8 | 9.6 | 14 |
| SD | 6.1 | 1.1 | 3.1 | 0.8 | 4.6 | 1.0 | 11.2 | 9.4 |
| p | 0.0017 | 0.0017 | 0.0017 | 0.085 | ||||